• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
COVID-19 convalescent plasma: phase 2.COVID-19 恢复期血浆：第 2 阶段。
Transfusion. 2020 Jun;60(6):1332-1333. doi: 10.1111/trf.15842. Epub 2020 May 12.
2
Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design.恢复期血浆治疗 2019 冠状病毒病（COVID-19）：临床试验设计的考虑因素。
Transfusion. 2020 Jun;60(6):1123-1127. doi: 10.1111/trf.15843. Epub 2020 May 12.
3
Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.来自新冠病毒感染康复者的捐赠者血浆——优先事项问题
Transfus Clin Biol. 2020 Aug;27(3):167-168. doi: 10.1016/j.tracli.2020.05.002. Epub 2020 Jun 12.
4
Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date.恢复期供体的新冠病毒特异性细胞毒性T淋巴细胞输注作为重症COVID-19患者的一种可能治疗选择，迄今为止尚未得到足够关注。
Br J Haematol. 2020 Jun;189(6):1062-1063. doi: 10.1111/bjh.16780. Epub 2020 May 19.
5
Convalescent Plasma: Promise for COVID-19 Pandemic.恢复期血浆：对新冠疫情的希望
J Coll Physicians Surg Pak. 2020 Jun;30(6):88. doi: 10.29271/jcpsp.2020.Supp1.S88.
6
Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.2019冠状病毒病（COVID-19）与免疫参与性癌症治疗
JAMA Oncol. 2020 Oct 1;6(10):1529-1530. doi: 10.1001/jamaoncol.2020.2367.
7
The convalescent sera option for containing COVID-19.使用康复期血清来控制新型冠状病毒肺炎。
J Clin Invest. 2020 Apr 1;130(4):1545-1548. doi: 10.1172/JCI138003.
8
The resurgence of convalescent plasma therapy.恢复期血浆疗法的复兴。
Lancet Haematol. 2020 May;7(5):e353. doi: 10.1016/S2352-3026(20)30117-4.
9
COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies.新型冠状病毒肺炎：冠状病毒复制、发病机制及治疗策略
Cleve Clin J Med. 2020 Jun;87(6):321-327. doi: 10.3949/ccjm.87a.20047. Epub 2020 May 4.
10
Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation.COVID-19 恢复期血浆捐献者的特征和血清学模式：最佳捐献者和捐献时间。
Transfusion. 2020 Aug;60(8):1765-1772. doi: 10.1111/trf.15918. Epub 2020 Jul 6.

引用本文的文献

1
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update.用于COVID-19治疗的康复期血浆（高免疫球蛋白）：最新情况
Process Biochem. 2023 Apr;127:66-81. doi: 10.1016/j.procbio.2023.01.018. Epub 2023 Jan 31.
2
Clinical nursing care protocol for convalescent plasma transfusion in patients with COVID-19.新型冠状病毒肺炎患者恢复期血浆输注的临床护理方案
Int J Afr Nurs Sci. 2023;18:100518. doi: 10.1016/j.ijans.2022.100518. Epub 2022 Dec 13.
3
Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency - Three consecutive cases and review of the literature.COVID-19 患者的恢复期血浆治疗伴体液免疫缺陷：连续 3 例病例并文献复习。
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Nov;40(9):507-516. doi: 10.1016/j.eimce.2021.01.009.
4
Effect of convalescent plasma therapy on mortality in moderate-to-severely Ill COVID-19 patients.恢复期血浆疗法对中重度 COVID-19 患者死亡率的影响。
Transfus Apher Sci. 2022 Dec;61(6):103455. doi: 10.1016/j.transci.2022.103455. Epub 2022 May 11.
5
SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors.接受来自正常和接种疫苗供体的新冠康复期血浆的新冠肺炎患者体内的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体变化
Transfus Apher Sci. 2022 Apr;61(2):103326. doi: 10.1016/j.transci.2021.103326. Epub 2021 Nov 23.
6
WOANet: Whale optimized deep neural network for the classification of COVID-19 from radiography images.WOANet：用于从X光图像中对新冠肺炎进行分类的鲸鱼优化深度神经网络。
Biocybern Biomed Eng. 2021 Oct-Dec;41(4):1702-1718. doi: 10.1016/j.bbe.2021.10.004. Epub 2021 Oct 23.
7
Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key.用于2019冠状病毒病的恢复期血浆：剂量是关键。
J Transl Int Med. 2021 Jul 9;9(2):68-70. doi: 10.2478/jtim-2021-0029. eCollection 2021 Jun.
8
Exponential increase in neutralizing and spike specific antibodies following vaccination of COVID-19 convalescent plasma donors.接种 COVID-19 恢复期血浆供者疫苗后，中和抗体和刺突特异性抗体呈指数增长。
Transfusion. 2021 Jul;61(7):2099-2106. doi: 10.1111/trf.16401. Epub 2021 Apr 15.
9
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.恢复期血浆用于 COVID-19 的预防和治疗：系统评价和定量分析。
JMIR Public Health Surveill. 2021 Apr 7;7(4):e25500. doi: 10.2196/25500.
10
Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency - Three consecutive cases and review of the literature.用恢复期血浆治疗体液免疫缺陷患者的新型冠状病毒肺炎——三例连续病例及文献综述
Enferm Infecc Microbiol Clin (Engl Ed). 2021 Feb 11;40(9):507-16. doi: 10.1016/j.eimc.2021.01.013.

COVID-19 恢复期血浆：第 2 阶段。

COVID-19 convalescent plasma: phase 2.

机构信息

DeGowin Blood Center, Department of Pathology, University of Iowa Hospitals & Clinics (UIHC), Iowa City, Iowa, USA.

出版信息

Transfusion. 2020 Jun;60(6):1332-1333. doi: 10.1111/trf.15842. Epub 2020 May 12.

DOI:10.1111/trf.15842
PMID:32374890
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7267265/
Abstract

See editorial on page 1123–1127, in this issue

摘要

见本期第 1123–1127 页社论